Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedA notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.SummaryDifference0.8%

- Check36 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study record content appears unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedThe footer's site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry (v3.7.0) was added to the record history and the older revision (v3.6.6) was removed, updating the visible version history of the page. This reflects an update to the page's version history rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.